Phio Pharmaceuticals receives U.S. patent allowance for PH-894
Phio Pharmaceuticals has received a U.S. Notice of Allowance for a patent covering PH-894, a compound designed to silence BRD4, a gene expression regulator linked to proliferative and infectious diseases. This patent strengthens the company's commitment to advancing PH-894 in the U.S. and seeking …